Esketamine's Therapeutic Effect on Anhedonia: A Post-hoc of a Randomized Controlled Trial
Research Square July 20, 2026 preprint DOI: 10.21203/rs.3.rs-10020524/v1 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial, post-hoc analysis |
|---|---|
| Population | Patients with treatment-resistant depression |
| Intervention | Esketamine |
| Topics | Esketamine |
| Key findings | Esketamine reduced anhedonia symptoms compared to placebo in patients with treatment-resistant depression. |
Abstract
Esketamine's Therapeutic Effect on Anhedonia: A Post-hoc of a Randomized Controlled Trial